Phanstiel S. Louise 4
4 · MYRIAD GENETICS INC · Filed Jun 4, 2021
Insider Transaction Report
Form 4
Phanstiel S. Louise
Director
Transactions
- Award
Common Stock
2021-06-03+12,848→ 79,527 total
Holdings
- 21,000(indirect: By Trust)
Common Stock
Footnotes (2)
- [F1]Consists of restricted stock units granted pursuant to Myriad Genetics, Inc.'s 2017 Employee, Director and Consultant Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of common stock and vests on the anniversary of the date of grant.
- [F2]The Reporting Person previously reported total beneficial ownership of 82,679 shares of common stock held directly and 5,000 shares of common stock held indirectly through The Phanstiel Trust. Except for the acquisition of 12,848 shares of common stock reported in this Form 4, the Reporting Person's total beneficial ownership of shares of common stock has not changed, but this Form 4 corrects the number of shares of common stock held directly by the Reporting Person and held indirectly by the Reporting Person through The Phanstiel Trust.